Central nervous system complications of sickle cell disease in children: An overview

Child Neuropsychology

Volumn 13, Issue 2, 2007, Pages 103-119

  Wang, Winfred C ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Central nervous system; Sickle cell disease; Silent cerebral infarct; Stroke; Transcranial Doppler ultrasonography (TCD)

Indexed keywords

DEFERASIROX; DEFEROXAMINE; HYDROXYUREA; PETHIDINE;

ACADEMIC ACHIEVEMENT; ACUTE CHEST SYNDROME; ALPHA THALASSEMIA; ASTHMA; BLOOD CLOTTING; BLOOD TRANSFUSION; BRAIN ARTERY ANEURYSM; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN NECROSIS; BRAIN REGION; CENTRAL NERVOUS SYSTEM DISEASE; CEREBRAL SINUS THROMBOSIS; CEREBROVASCULAR ACCIDENT; CYTAPHERESIS; DOPPLER ECHOGRAPHY; ERYTHROCYTAPHERESIS; HEADACHE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; IRON CHELATION; IRON OVERLOAD; LEUKOENCEPHALOPATHY; MAGNETIC RESONANCE ANGIOGRAPHY; MIGRAINE; MUTATIONAL ANALYSIS; NECROTIZING ENCEPHALOPATHY; NEUROIMAGING; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PHLEBOTOMY; PROPHYLAXIS; REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; REVIEW; RISK ASSESSMENT; SCHOOL; SCREENING; SECONDARY PREVENTION; SEIZURE; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE; TRANSIENT ISCHEMIC ATTACK;

ANEMIA, SICKLE CELL; BRAIN DISEASES; CEREBRAL INFARCTION; CHILD; HUMANS; LEARNING DISORDERS; MASS SCREENING; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 33847776875     PISSN: 09297049     EISSN: 17444136     Source Type: Journal    
DOI: 10.1080/09297040600788136     Document Type: Review

References (87)

1. Adams, R. J., & Brambilla, D. (2005). Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. New England Journal of Medicine, 353, 2769-2778.
2. Adams, R. J., Kutlar, A., McKie, V., Carl, E., Fenwick, T. N., Liu, J. C., et al. (1994). Alpha thalassemia and stroke risk in sickle cell anemia. American Journal of Hematology, 45, 279-282.
3. Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., et al. (1998). Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. New England Journal of Medicine, 339, 5-11.
4. Adams, R., McKie, V., Nichols, F., Carl, E., Zhang, D. L., McKie, K., et al. (1992). The use of transcranial ultrasonography to predict stroke in sickle cell disease. New England Journal of Medicine, 326, 605-610.
5. Adams, R. J., Nichols, F. T., III, Aaslid, R., McKie, V. C., McKie, K., Carl, E., et al. (1990). Cerebral vessel stenosis in sickle cell disease: Criteria for detection by transcranial Doppler. American Journal of Pediatric Hematology Oncology, 12, 277-282.
6. Albers, G. W., Caplan, L. R., Easton, J. D., Fayad, P. B., Mohr, J. P., Saver, J. L., et al. (2002). Transient ischemic attack-proposal for a new definition. New England Journal of Medicine, 347, 1713-1716.
7. Armstrong, F. D., Thompson, R. J., Jr., Wang, W., Zimmerman, R., Pegelow, C. H., Miller, S., et al. (1996). Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics, 97, 864-870.
8. Bakhshi, S., Sarnaik, S. A., Becker, C., Shurney, W. W., Nigro, M., & Savasan, S. (2002). Acute encephalopathy with parvovirus B19 infection in sickle cell disease. Archives of Disease in Children, 87, 541-542.
9. Bernaudin, F., Verlhac, S., Freard, F., Roudot-Thoraval, F., Benkerrou, M., Thuret, I., et al. (2000). Multicenter prospective study of children with sickle cell disease: Radiographic and psychometric correlation. Journal of Child Neurology, 15, 333-343.
10. Buchanan, G. R., DeBaun, M. R., Quinn, C. T., & Steinberg, M. H. (2004). Sickle cell disease. Hematology (American Society of Hematology Education Program), 35-47.
11. Bulas, D. I., Jones, A., Seibert, J. J., Driscoll, C., O'Donnell, R., & Adams, R. J. (2000). Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: Pitfalls in technique variation. Pediatric Radiology, 30, 733-738.
12. Chua-Lim, C., Moore, R. B., McCleary, G., Shah, A., & Mankad, V. N. (1993). Deficiencies in school readiness skills of children with sickle cell anemia: A preliminary report. Southern Medical Journal, 86, 397-402.
13. Dobson, S. R., Holden, K. R., Nietert, P. J., Cure, J. K., Laver, J. H., Disco, D., et al. (2002). Moyamoya syndrome in childhood sickle cell disease: A predictive factor for recurrent cerebrovascular events. Blood, 99, 3144-3150.
14. Driscoll, M. C., Hurlet, A., Styles, L., McKie, V., Files, B., Olivieri, N., et al. (2003). Stroke risk in siblings with sickle cell anemia. Blood, 101, 2401-2404.
15. Francis, R. B., Jr. (1991). Platelets, coagulation, and fibrinolysis in sickle cell disease: Their possible role in vascular occlusion. Blood Coagulation and Fibrinolysis, 2, 341-353.
16. Fullerton, H. J., Adams, R. J., Zhao, S., & Johnston, S. C. (2004). Declining stroke rates in Californian children with sickle cell disease. Blood, 104, 336-339.
17. Gulbis, B., Haberman, D., Dufour, D., Christophe, C., Vermylen, C., Kagambega, F., et al. (2005). Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: The Belgian experience. Blood, 105, 2685-2690.
18. Hale, D., Davis, P., Gentry, B., & Dancer, J. (1999). 25 facts on sickle cell disease: A regional survey of public school nurses. Perceptual and Motor Skills, 89, 1043-1046.
19. Henderson, J. N., Noetzel, M. J., McKinstry, R. C., White, D. A., Armstrong, M., & DeBaun, M. R. (2003). Reversible posterior leukoencephalopathy syndrome and silent cerebral infarcts are associated with severe acute chest syndrome in children with sickle cell disease. Blood, 101, 415-419.
20. Herrick, J. B. (1910). Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Archives of Internal Medicine, 6, 517-521.
21. Hillery, C. A., & Panepinto, J. A. (2004). Pathophysiology of stroke in sickle cell disease. Microcirculation, 11, 195-208.
22. Hinchey, J., Chaves, C., Appignani, B., Breen, J., Pao, L., Wang, A., et al. (1996). A reversible posterior leukoencephalopathy syndrome. New England Journal of Medicine, 334, 494-500.
23. Hindmarsh, P. C., Brozovic, M., Brook, C. G. D., & Davies, S. C. (1987). Incidence of Overt and Covert Neurological Damage in Children with Sickle-Cell Disease. Postgraduate Medical Journal, 63, 751-753.
24. Hoppe, C. (2004). Defining stroke risk in children with sickle cell anemia. British Jounal of Haematology, 128, 751-766.
25. Hoppe, C., Klitz, W., Noble, J., Vigil, L., Vichinsky, E., & Styles, L. (2003). Distinct HLA associations by stroke subtype in children with sickle cell anemia. Blood, 101, 2865-2869.
26. Ingram, V. M. (1957). Gene mutations in human haemoglobin: The chemical difference between normal and sickle cell haemoglobin. Nature, 180, 326-328.
27. Jones, A. M., Seibert, J. J., Nichols, F. T., Kinder, D. L., Cox, K., Luden, J., et al. (2001). Comparison of transcranial color Doppler imaging (TCDI) and transcranial Doppler (TCD) in children with sickle-cell anemia. Pediatric Radiology, 31, 461-469.
28. Katz, M. L., Smith-Whitley, K., Ruzek, S. B., & Ohene-Frempong, K. (2002). Knowledge of stroke risk, signs of stroke, and the need for stroke education among children with sickle cell disease and their caregivers. Ethnicity and Health, 7, 115-123.
29. Kaul, D. K., Liu, X. D., Fabry, M. E., & Nagel, R. L. (2000). Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse. American Journal of Physiology - Heart and Circulatory Physiology, 278, H1799-H1806.
30. King, A. A., Tang, S., Ferguson, K. L., & DeBaun, M. R. (2005). An education program to increase teacher knowledge about sickle cell disease. Journal of School Health, 75, 11-14.
31. Kinney, T. R., Sleeper, L. A., Wang, W. C., Zimmerman, R. A., Pegelow, C. H., Ohene-Frempong, K., et al. (1999). Silent cerebral infarcts in sickle cell anemia: A risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics, 103, 640-645.
32. Kirkham, F. J., Calamante, F., Bynevelt, M., Gadian, D. G., Evans, J. P., Cox, T. C., et al. (2001a). Perfusion magnetic resonance abnormalities in patients with sickle cell disease. Annals of Neurology, 49, 477-485.
33. Kirkham, F. J., Hewes, D. K., Prengler, M., Wade, A., Lane, R., & Evans, J. P. (2001b). Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease. Lancet, 357, 1656-1659.
34. Koontz, K., Short, A. D., Kalinyak, K., & Noll, R. B. (2004). A randomized, controlled pilot trial of a school intervention for children with sickle cell anemia. Journal of Pediatric Psychology, 29, 7-17.
35. Koshy, M., Thomas, C., & Goodwin, J. (1990). Vascular lesions in the central nervous system in sickle cell disease (neuropathology). Journal of the Association for Academic Minority Physicians, 1, 71-78.
36. Kral, M. C., Brown, R. T., Nietert, P. J., Abboud, M. R., Jackson, S. M., & Hynd, G. W. (2003). Transcranial Doppler ultrasonography and neurocognitive functioning in children with sickle cell disease. Pediatrics, 112, 324-331.
37. Kuypers, F. A., Lewis, R. A., Hua, M., Schott, M. A., Discher, D., Ernst, J. D., et al. (1996). Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood, 87, 1179-1187.
38. Lee, K. H., McKie, V. C., Sekul, E. A., Adams, R. J., & Nichols, F. T. (2002). Unusual encephalopathy after acute chest syndrome in sickle cell disease: Acute necrotizing encephalitis. Journal of Pediatric Hematology Oncology, 24, 585-588.
39. Liu, J. E., Gzesh, D. J., & Ballas, S. K. (1994). The spectrum of epilepsy in sickle cell anemia. Journal of the Neurological Sciences, 123, 6-10.
40. McCarville, M. B., Li, C., Xiong, X., & Wang, W. (2004). Comparison of transcranial Doppler sonography with and without imaging in the evaluation of children with sickle cell anemia. American Journal of Roentgenology, 183, 1117-1122.
41. Miller, S. T., Macklin, E. A., Pegelow, C. H., Kinney, T. R., Sleeper, L. A., Bello, J. A., et al. (2001). Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: A report from the Cooperative Study of Sickle Cell Disease. Journal of Pediatrics, 139, 385-390.
42. Moser, F. G., Miller, S. T., Bello, J. A., Pegelow, C. H., Zimmerman, R. A., Wang, W. C., et al. (1996). The spectrum of brain MR abnormalities in sickle-cell disease: A report from the Cooperative Study of Sickle Cell Disease. American Journal of Neuroradiology, 17, 965-972.
43. Neish, A. S., Blews, D. E., Simms, C. A., Merritt, R. K., & Spinks, A. J. (2002). Screening for stroke in sickle cell anemia: Comparison of transcranial Doppler imaging and nonimaging US techniques. Radiology, 222, 709-714.
44. Nettles, A. L. (1994). Scholastic performance of children with sickle cell disease. J Health Soc.Policy, 5, 123-140.
45. Nordness, M. E., Lynn, J., Zacharisen, M. C., Scott, P. J., & Kelly, K. J. (2005). Asthma is a risk factor for acute chest syndrome and cerebral vascular accidents in children with sickle cell disease. Clinicial and Molecular Allergy, 3, 2.
46. Ogunfowora, O. B., Olanrewaju, D. M., & Akenzua, G. I. (2005). A comparative study of academic achievement of children with sickle cell anemia and their healthy siblings. Journal of the National Medical Association, 97, 405-408.
47. Oguz, M., Aksungur, E. H., Soyupak, S. K., & Yildirim, A. U. (1994). Vein of Galen and sinus thrombosis with bilateral thalamic infarcts in sickle cell anaemia: CT follow-up and angiographic demonstration. Neuroradiology, 36, 155-156.
48. Ohene-Frempong, K., Weiner, S. J., Sleeper, L. A., Miller, S. T., Embury, S., Moohr, J. W., et al. (1998). Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood, 91, 288-294.
49. Osarogiagbon, U. R., Choong, S., Belcher, J. D., Vercellotti, G. M., Paller, M. S., & Hebbel, R. P. (2000). Reperfusion injury pathophysiology in sickle transgenic mice. Blood, 96, 314-320.
50. Oyesiku, N. M., Barrow, D. L., Eckman, J. R., Tindall, S. C., & Colohan, A. R. (1991). Intracranial aneurysms in sickle-cell anemia: Clinical features and pathogenesis. Journal of Neurosurgery, 75, 356-363.
51. Palermo, T. M., Platt-Houston, C., Kiska, R. E., & Berman, B. (2005). Headache symptoms in pediatric sickle cell patients. Journal of Pediatric Hematology Oncology, 27, 420-424.
52. Pavlakis, S. G., Bello, J., Prohovnik, I., Sutton, M., Ince, C., Mohr, J. P., et al. (1988). Brain infarction in sickle cell anemia: Magnetic resonance imaging correlates. Annals of Neurology, 23, 125-130.
53. Pavlakis, S. G., Frank, Y., & Chusid, R. (1999). Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: Three names for an old syndrome. Journal of Child Neurology, 14, 277-281.
54. Pegelow, C. H., Adams, R. J., McKie, V., Abboud, M., Berman, B., Miller, S. T., et al. (1995). Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. Journal of Pediatrics, 126, 896-899.
55. Pegelow, C. H., Macklin, E. A., Moser, F. G., Wang, W. C., Bello, J. A., Miller, S. T., et al. (2002). Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood, 99, 3014-3018.
56. Pegelow, C. H., Wang, W., Granger, S., Hsu, L. L., Vichinsky, E., Moser, F. G., et al. (2001). Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity. Archives of Neurology, 58, 2017-2021.
57. Powars, D., Wilson, B., Imbus, C., Pegelow, C., & Allen, J. (1978). The natural history of stroke in sickle cell disease. American Journal of Medicine, 65, 461-471.
58. Powars, D. R., Conti, P. S., Wong, W. Y., Groncy, P., Hyman, C., Smith, E., et al. (1999). Cerebral vasculopathy in sickle cell anemia: Diagnostic contribution of positron emission tomography. Blood, 93, 71-79.
59. Prengler, M., Pavlakis, S. G., Boyd, S., Connelly, A., Calamante, F., Chong, W. K., et al. (2005). Sickle cell disease: Ischemia and seizures. Annals of Neurology, 58, 290-302.
60. Rana, S., Houston, P. E., Surana, N., Shalaby-Rana, E. I., & Castro, O. L. (1997). Discontinuation of long-term transfusion therapy in patients with sickle cell disease and stroke. Journal of Pediatrics, 131, 757-760.
61. Reed, W., Jagust, W., Al Mateen, M., & Vichinsky, E. (1999). Role of positron emission tomography in determining the extent of CNS ischemia in patients with sickle cell disease. American Journal of Hematology, 60, 268-272.
62. Rothman, S. M., Fulling, K. H., & Nelson, J. S. (1986). Sickle cell anemia and central nervous system infarction: A neuropathological study. Annals of Neurology, 20, 684-690.
63. Russell, M. O., Goldberg, H. I., Hodson, A., Kim, H. C., Halus, J., Reivich, M., et al. (1984). Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood, 63, 162-169.
64. Sarnaik, S., Soorya, D., Kim, J., Ravindranath, Y., & Lusher, J. (1979). Periodic transfusions for sickle cell anemia and CNS infarction. American Journal of Diseases of Children, 133, 1254-1257.
65. Schatz, J., Brown, R. T., Pascual, J. M., Hsu, L., & DeBaun, M. R. (2001). Poor school and cognitive functioning with silent cerebral infarcts and sickle cell disease. Neurology, 56, 1109-1111.
66. Schatz, J. (2004). Brief report: Academic attainment in children with sickle cell disease. Journal of Pediatric Psychology, 29, 627-633.
67. Scothorn, D. J., Price, C., Schwartz, D., Terrill, C., Buchanan, G. R., Shurney, W., et al. (2002). Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. Journal of Pediatrics, 140, 348-354.
68. Sebastiani, P., Ramoni, M. F., Nolan, V., Baldwin, C. T., Steinberg, M. H. (2005). Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nature Genetics, 37, 435-440.
69. Steen, R. G., Hu, X. J., Elliott, V. E., Miles, M. A., Jones, S., & Wang, W. C. (2002). Kindergarten readiness skills in children with sickle cell disease: Evidence of early neurocognitive damage? Journal of Child Neurology, 17, 111-116.
70. Stockman, J. A., Nigro, M. A., Mishkin, M. M., & Oski, F. A. (1972). Occlusion of large cerebral vessels in sickle-cell anemia. New England Journal of Medicine, 287, 846-849.
71. Sydenstricker, V. P. (1923). Sickle cell anemia. report of two cases in children, with necropsy in one case. American Journal of Diseases of Children, 26, 132-154.
72. Taylor IV, J. G., Tang, D. C., Savage, S. A., Leitman, S. F., Heller, S. I., Serjeant, G. R., et al. (2002). Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood, 100, 4303-4309.
73. Thompson, R. J., Jr., Gustafson, K. E., Bonner, M. J., & Ware, R. E. (2002). Neurocognitive development of young children with sickle cell disease through three years of age. Journal of Pediatric Psychology, 27, 235-244.
74. Van Hoff, J., Ritchey, A. K., & Shaywitz, B. A. (1985). Intracranial hemorrhage in children with sickle cell disease. American Journal of Diseases of Children, 139, 1120-1123.
75. van Mierlo, T. D., van den Berg, H. M., Nievelstein, R. A., & Braun, K. P. (2003). An unconscious girl with sickle-cell disease. Lancet, 361, 136.
76. Vermylen, C. (2003). Hematopoietic stem cell transplantation in sickle cell disease. Blood Review, 17, 163-166.
77. Vichinsky, E. P., Neumayr, L. D., Earles, A. N., Williams, R., Lennette, E. T., Dean, D., et al. (2000). Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. New England Journal of Medicne, 342, 1855-1865.
78. Walters, M. C., Storb, R., Patience, M., Leisenring, W., Taylor, T., Sanders, J. E., et al. (2000). Impact of bone marrow transplantation for symptomatic sickle cell disease: An interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood, 95, 1918-1924.
79. Wang, W., Enos, L., Gallagher, D., Thompson, R., Guarini, L., Vichinsky, E., et al. (2001). Neuropsychologic performance in school-aged children with sickle cell disease: A report from the Cooperative Study of Sickle Cell Disease. Journal of Pediatrics, 139, 391-397.
80. Wang, W. C., Kovnar, E. H., Tonkin, I. L., Mulhern, R. K., Langston, J. W., Day, S. W., et al. (1991). High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. Journal of Pediatrics, 118, 377-382.
81. Wang, W. C., Langston, J. W., Steen, R. G., Wynn, L. W., Mulhern, R. K., Wilimas, J. A. et al. (1998). Abnormalities of the central nervous system in very young children with sickle cell anemia. Journal of Pediatrics, 132, 994-998.
82. Wang, Z., Bogdan, A. R., Zimmerman, R. A., Gusnard, D. A., Leigh, J. S., & Ohene-Frempong, K. (1992). Investigation of stroke in sickle cell disease by 1H nuclear magnetic resonance spectroscopy. Neuroradiology, 35, 57-65.
83. Ware, R. E., Zimmerman, S. A., Sylvestre, P. B., Mortier, N. A., Davis, J. S., Treem, W. R., et al. (2004). Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy. Journal of Pediatrics, 145, 346-352.
84. Wilimas, J., Goff, J. R., Anderson, H. R., Jr., Langston, J. W., & Thompson, E. (1980). Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents. Journal of Pediatrics, 96, 205-208.
85. Woodard, P., Helton, K. J., Khan, R. B., Hale, G. A., Phipps, S., Wang, W., et al. (2005). Brain parenchymal damage after haematopoietic stem cell transplantation for severe sickle cell disease. British Journal of Haematology, 129, 550-552.
86. Yerys, B. E., White, D. A., Salorio, C. F., McKinstry, R., Moinuddin, A., & DeBaun, M. (2003). Memory strategy training in children with cerebral infarcts related to sickle cell disease. Journal of Pediatric Hematology Oncology, 25, 495-498.
87. Zimmerman, S. A., Schultz, W. H., Davis, J. S., & Ware, R. E. (2002). Hydroxyurea therapy lowers transcranial doppler flow velocities in children with sickle cell anemia. Blood, 100, 10.